Table 2.
The prognostic value of PCDH17 methylation for the BCR-free survival in univariate and multivariate Cox regression analysis.
| Varivale | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| Exp (B) | 95% CI | P | Exp (B) | 95% CI | P | |
| Age | 1.003 | 0.693–1.537 | 0.874 | 1.425 | 0.819–6.305 | 0.067 |
| PSA | 2.537 | 1.049–3.641 | 0.003 | |||
| Pathologic Stage | 1.104 | 0.921–2.466 | 0.571 | |||
| Gleason score | 3.237 | 1.369–5.824 | <0.001 | 1.875 | 1..43–4.382 | 0.001 |
| Lymph node status | 1.136 | 0.798–2.594 | 0.542 | |||
| Surgical margin status | 1.078 | 0.896–1.763 | 0.755 | |||
| PCDH17 methylation | 4.331 | 1.783–6.583 | <0.001 | 3.167 | 1.534–5.073 | <0.001 |